MedTrace Logo

The Role of Fatty Acids in Vaccine Efficacy

NCT05987384 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2023-08-14

No results posted yet for this study

Summary

This study intends to use a randomized controlled trial design to vaccinate all participants against rabies and perform ARA interventions during vaccination to test the efficacy, safety, and intestinal flora of each group after immunization.

Conditions

  • Rabies Vaccination Reaction

Interventions

DIETARY_SUPPLEMENT

Arachidonic acid

D3 ARA group will receive ARA capsules from the third day of the study. D6 ARA group will receive ARA capsules from the sixth day of the study

DIETARY_SUPPLEMENT

Sunflower oil

The placebo group and D6 ARA group will receive sunflower oil capsules from the third day of the study. D6 ARA group will stop receiving sunflower oil capsules from the fifth day of the study.

BIOLOGICAL

Rabies Vaccine (Vero Cell) for Human Use

Every participant will receive three doses of rabies vaccination.

Sponsors & Collaborators

  • Tsinghua University

    lead OTHER

Principal Investigators

  • Ai Zhao, Doctor · Tsinghua University

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-05-03
Primary Completion
2023-07-30
Completion
2023-07-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05987384 on ClinicalTrials.gov